Profile data is unavailable for this security.
About the company
LBX Pharmacy Chain JSC is a China-based company principally engaged in the sale of pharmaceuticals, other health and beauty related products. The Company operates its businesses through three segments. Retail segment is mainly engaged in the business of retailing goods. Wholesale segment is mainly involved in the wholesale business of merchandise. Other Business segment is mainly involved in the pharmaceutical manufacturing and other businesses. The Company’s main products comprise proprietary Chinese and western medicines, Chinese herbal medicines, health maintenance Chinese medicines, health equipment, health foods, general foods, personal care products and household appliances. The Company mainly conducts its businesses in the domestic market.
- Revenue in CNY (TTM)22.54bn
- Net income in CNY958.95m
- Incorporated2005
- Employees40.88k
- LocationLBX Pharmacy Chain JSCNo. 808, Qingzhuhu Road, Kaifu DistrictCHANGSHA 410152ChinaCHN
- Phone+86 73 184035189
- Fax+86 73 184035196
- Websitehttps://www.lbxdrugs.com/
Mergers & acquisitions
| Acquired company | 603883:SHH since announced | Transaction value |
|---|---|---|
| Yangzhou Baixinyuan Pharmaceutical Chain Co Ltd | -40.50% | 29.38m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chongqing Department Store Co. Ltd | 18.73bn | 1.28bn | 8.20bn | 12.62k | 5.89 | 1.12 | -- | 0.438 | 3.12 | 3.12 | 46.08 | 16.47 | 0.9919 | 6.30 | 70.66 | 1,483,641.00 | 6.85 | 6.38 | 13.25 | 13.27 | 25.07 | 21.57 | 6.91 | 4.69 | 0.6437 | -- | 0.4726 | 73.25 | 3.72 | -11.04 | 48.84 | 9.61 | -15.66 | 15.84 |
| LBX Pharmacy Chain JSC | 22.54bn | 958.95m | 11.65bn | 40.88k | 12.09 | 1.65 | -- | 0.5168 | 1.27 | 1.27 | 29.77 | 9.29 | 1.06 | 3.61 | 11.24 | 551,261.10 | 5.40 | 5.73 | 11.29 | 12.96 | 32.73 | 32.33 | 5.11 | 5.08 | 0.4795 | 13.19 | 0.557 | 33.18 | 11.21 | 18.83 | 18.35 | 16.39 | -6.60 | 19.16 |
| Shanghai Bailian Group Co Ltd | 29.86bn | 380.13m | 12.38bn | 22.25k | 34.64 | 0.7345 | -- | 0.4146 | 0.213 | 0.213 | 16.74 | 10.05 | 0.5305 | 7.91 | 47.75 | 1,341,962.00 | -0.1733 | 1.03 | -0.3336 | 2.02 | 25.22 | 24.31 | -0.3266 | 1.55 | 0.9212 | 2.85 | 0.3951 | 32.13 | -5.47 | -8.82 | -40.79 | -14.47 | -3.42 | -7.79 |
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 22.10m | 2.92% |
| Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 19.27m | 2.54% |
| Rongtong Fund Management Co., Ltd.as of 30 Sep 2023 | 14.31m | 1.89% |
| FIL Investment Management (Singapore) Ltd.as of 31 May 2024 | 7.79m | 1.03% |
| First Sentier Investors (UK) IM Ltd.as of 31 Mar 2024 | 6.62m | 0.87% |
| FIL Investment Management (Hong Kong) Ltd.as of 31 May 2024 | 6.29m | 0.83% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 5.50m | 0.73% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 3.62m | 0.48% |
| Caitong Securities Asset Management Co., Ltd.as of 31 Dec 2023 | 3.32m | 0.44% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 3.11m | 0.41% |
